1 |
Korn, E. L., Midthune, D., Chen, T. T., Rubinstein, L. V., Christian, M. C. and Simon, R. (1994). A Comparison of two phase I trial designs, Statistics in Medicine, 13, 1799-1806
DOI
ScienceOn
|
2 |
O’Quigley, J., Pepe, M. and Fisher, L. (1990). Continual reassessment method: A practical design for phase 1 clinical trials in cancer, Biometrics, 46, 33-48
DOI
ScienceOn
|
3 |
O'Quigley. J. and Shen, L. Z. (1996). Continual reassessment method: A likelihood approach, Biometrics, 52, 673-684
DOI
ScienceOn
|
4 |
Simon, R., Freidlin, B., Rubinstein, L., Arbuck, S. G., Collins, J. and Christian, M. C. (1997). Accelerated titration designs for phase I clinical trials in oncology, Journal of the National Cancer Institute, 89, 1138-1147
DOI
ScienceOn
|
5 |
Storer, B. E. (1989). Design and analysis of phase I clinical trials, Biometrics, 45, 925-937
DOI
ScienceOn
|
6 |
강승호 (2002). 1상 임상실험에서 수정된 CRM에 대한 연구, <응용통계연구>, 15, 323-336
과학기술학회마을
DOI
|
7 |
Kang, S. H. (2003). Consistency and asymptotic normality of a modified likelihood approach continual reassessment method, Journal of the Korean Statistical Society, 32, 33-46
과학기술학회마을
|